Skip to content

ABC Tool

  • Home
  • About / Contect
    • PRIVACY POLICY
Man dies covered in necrotic lesions after amoebas eat him alive

Man dies covered in necrotic lesions after amoebas eat him alive

Posted on May 1, 2026 By safdargal12 No Comments on Man dies covered in necrotic lesions after amoebas eat him alive
Blog

Of all the known ways to get an Acanthamoeba infection, nasal rinsing was the most likely one in the man’s case. The man had nasal polyps and used sinus rinses to alleviate his symptoms. However, his symptoms didn’t start in his nasal passages—they started on his legs. There, red nodules formed and progressed to develop dark centers. Some became deep ulcers, while others became necrotic, turning to black scabs. Then began erupting on his trunk, arms, and neck.

Catching a killer

Before his transfer to Yale, doctors elsewhere tried to identify the mysterious cause, doing multiple biopsies of his diseased skin. Tests were negative for bacterial or fungal pathogens. But they showed his blood vessels were inflamed and full of clumps of immune cells. Doctors worried that his immune system was attacking his blood vessels, causing the necrotic lesions. So, they put him on immunosuppressant drugs. But his condition only worsened, and the lesions only progressed. When he arrived at Yale, he had a fever and high heart rate, and appeared frail. He had lost 16 pounds and was drowsy and confused. He was blanketed in lesions.

The Yale doctors noted that the lesions began after he returned from Florida, where he spent the winters. While there, he was exposed to a red tide (caused by algae) while cleaning up after a hurricane. Otherwise, he had a medical history of just the nasal polyps and asthma, which he treated with a monoclonal antibody drug, dupilumab. Given that his lesions progressed, they redid a skin biopsy, this time finding cells that looked like amoebas. DNA testing confirmed Acanthamoeba.

The doctors quickly put him on a five-drug regimen recommended for such infections by the Centers for Disease Control and Prevention, but he continued to deteriorate. They then sought and got approval from the Food and Drug Administration for a single-patient experimental trial of an antibiotic (nitroxoline) that had shown success in treating a different amoeba in another patient. Once the doctors started it in the man, it appeared to work. His fever broke briefly, some of his lesions improved, and no new ones formed.



Source link

Post Views: 20

Post navigation

❮ Previous Post: Credit Cards Are Vulnerable To Brute Force Kind Attacks
Next Post: Recovery Slides Are My Feet’s Best Friends. Here Are My Top Picks ❯

You may also like

Demis Hassabis said this might be the ‘foothills of the singularity.’ What?
Blog
Demis Hassabis said this might be the ‘foothills of the singularity.’ What?
May 20, 2026
Gemini Live’s new interactive bar reportedly waves back at users
Blog
Gemini Live’s new interactive bar reportedly waves back at users
May 15, 2026
Trump Phone Will Finally Ship This Week, Report Says
Blog
Trump Phone Will Finally Ship This Week, Report Says
May 13, 2026
One UI 8.5 for the Galaxy S24 series is now available globally
Blog
One UI 8.5 for the Galaxy S24 series is now available globally
May 19, 2026

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • I’m all for the under-16 social media ban, but we should be wary of how it’s implented
  • The Honor Robot Phone was used at the Shanghai International Film Festival
  • Samsung Built a Real Spider-Man Tracker You Can Use This Summer
  • The Ars Technica 2026 Reader Survey: Let your voice be heard!
  • building zero trust beyond identity

Recent Comments

  1. Last Chance for Big Savings on TechCrunch Disrupt 2026 Tickets – Artiverse on 5 days left: Save up to $410 on Disrupt 2026 passes

Archives

  • June 2026
  • May 2026
  • April 2026

Categories

  • Blog

Copyright © 2026 ABC Tool.

Theme: Oceanly News by ScriptsTown